Abstract
It has been hypothesized that there is an adrenal abnormality in the polycystic ovary syndrome (PCO). This study was undertaken to examine this hypothesis in a more physiological way, by enhancing the ACTH secretion in response to ovine corticotropin releasing hormone (oCRH) injection so that adrenal androgen and glucocorticoid responsiveness to endogenous stimulation could be examined. Plasma ACTH and the ACTH and Cortisol (F) response to oCRH were normal. The plasma T and dehydroepiandrosterone (DHEA) responses were also normal. The androstenedione (A) response, however, was exaggerated. This study supports the hypothesis that the adrenal gland in patients with PCO produces increased amounts of androstenedione in response to ACTH stimulation.
Similar content being viewed by others
References
De Vane G.W., Czekala N.M., Judd H.L., Yen S.S.C. Circulating gonadotropins, estrogens and androgens in polycystic ovarian disease. Am. J. Obstet. Gynecol. 121: 496, 1975.
Lachelin G.C.L., Barnett M., Hopper B.R., Brink G., Yen S.S.C. Adrenal function in normal women and women with the polycystic ovary syndrome. J. Clin. Endocrinol Metab. 49: 892, 1979.
Avgerinos P.C., Schurmeyer T.H., Gold P.W., Tomai T.P., Loriaux D.L., Sherins R.J., Cutler G.B.Jr., Chrousos G.P. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal Cortisol secretory pattern. J. Clin. Endocrinol. Metab. 62: 816, 1986.
Jackson R.V., De Cherney G.S., De Bold C.R., Sheldon W.R., Alexander A.N., Rivier J., Vale W., Orth D.N. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man. J. Clin. Endocrinol. Metab. 58: 740, 1984.
Givens J.R., Wiedeman E., Andersen R.N., Kitabchi A.E. β-endorphin and β-lipotropin plasma levels in hirsute women: correlation with body weight. J. Clin. Endocrinol. Metab. 50: 975, 1980.
Aleem F.A., Mcintosh T. Elevated plasma levels of β-ehdorphin in a group of women with polycystic ovarian disease. Fertil. Steril. 42: 686, 1984.
Seltzer C.C. Some re-evaluations of the build and blood pressure study 1959, as related to ponderal index, somatotype and mortality. N. Engl. J. Med. 274: 254, 1966.
Shulte H.M., Chrousos G.P., Booth J.D., Oldfield E.H., Gold P.W., Cutler G.B.Jr., Loriaux D.L. Corticotropin-releasing factor: pharmacokinetics in man. J. Clin. Endocrinol. Metab. 58: 192, 1984.
D’Agata R., Vicari E., Aliffi A., Maugeri G., Mongioì A., Gulizia S. Testicular responsiveness to chronic human chorionic gonadotropin administration in hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 55: 76, 1982.
Baird D.T., Corker C.S., Davidson D.W., Hunter W.M., Michie E.A., Van Look P.F.A. Pituitary-ovarian relationship in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 45: 798, 1977.
Yen S.S.C. The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 12: 177, 1980.
Chang R.J., Mandel F.P., Lu J.K.H., Judd H.L. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 54: 490, 1982.
Hoffmann D., Lobo R.A. Serum dehydroepiandrosterone sulfate and the use of Clomifene citrate in anovulatory women. Fertil. Steril. 43: 196, 1985.
Kandeel F.R., London D.R., Butt W.R., Davila N., Rudd B.T., Sadeghian S., Lynch S.S., Logan-Edwards R., Horder M. Adrenal function in subgroups of the polycystic ovary syndrome assessed by long ACTH test. Clin. Endocrinol. (Oxf.) 13: 601, 1980.
Lobo R.A., Goebelsmann U. Evidence for reduced 3 β-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 53: 394, 1981.
Givens J.R., Andersen R.N., Ragland J.B., Wiser W.L., Umstot E.S. Adrenal function in hirsutism: I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, Cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH. J. Clin. Endocrinol. Metab. 40: 988, 1975.
Loughlin T., Cunningham S., Moore A., Culliton M., Smyth P.P.A., McKenna T.J. Adrenal abnormalities in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 62: 142, 1986.
Chrousos G.P., Schulte H.M., Loriaux D.L., Oldfield E.H., Gold P.W. Corticotropin releasing factor: basic and clinical studies. Psychopharm. Bull. 19: 416, 1983.
Orth D.N., Jackson R.V., De Cherney G.S., De Bold G.R., Alexander A.N., Island D.P., Rivier C., Spiess J., Vale W. Effect of synthetic ovine corticotropin-releasing factor: dose-response of plasma adrenocorticotropin and Cortisol. J. Clin. Invest. 71: 587, 1983.
Kurtz B.R., Givens J.R., Komindr S., Stevens M.D., Karas J.G., Bittle J.B., Judge D., Kitabchi A.E. Maintenance of normal circulating levels of Δ4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism. J. Clin. Endocrinol. Metab. 64: 1261, 1987.
Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21: 1440, 1961.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mongioì, A., Macchi, M., Vicari, E. et al. Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome. J Endocrinol Invest 11, 637–640 (1988). https://doi.org/10.1007/BF03350202
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350202